World

Lupin Pharmaceuticals Recalls 2 Lots of TydemyTM Due to OOS Results

Lupin Pharmaceuticals Inc. (Lupin) is voluntarily recalling two (2) lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0....

 July 31, 2023 | News

Gilead Launches Global All4Liver Grant Program Towards WHO's 2030 Viral Hepatitis Elimination Goal

  –  Themed ‘Test. Link. Prioritize’, the Grant Program will Target Projects Focusing on Viral Hepatitis Elimination by 2030 &...

 July 28, 2023 | News

STARLIMS and Waker Bioscience Partner for Digital Transformation

Shanghai Waker Bioscience Co., Ltd. is an innovative company that complies with domestic regulatory requirements for viral integration site analysis (I...

 July 28, 2023 | News

MSD and Moderna Launch Phase 3 Study for Melanoma Treatment

“As we continue our efforts to advance novel treatment options for patients with high-risk Stage IIB-IV melanoma, the initiation of the V940-001 Phas...

 July 28, 2023 | News

Clarivate Enhances Patient Data Intelligence with German Hospital Prescribing Insights

 Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, ...

 July 28, 2023 | News

BioMap unveils a “Life Science Leaderboard” to compare AI models

Highlights:  New AI leaderboard provides comparison of 25+ of the most important, representative and cutting-edge tasks across six distinct...

 July 26, 2023 | News

Alma Veil™ Launched for U.S. Market by Sisram Medical's Alma

Alma Veil is the core instrument equipped with three gold-standard technologies conveniently integrated into a single handpiece: 532 nm laser:...

 July 26, 2023 | News

Fapon Unveils High-Throughput Chemiluminescence Immunoassay Analyzer

According to Mr. Kevin Liu, Global Sales Director of Fapon, "The Shine i8000/9000 Chemiluminescence Immunoassay Analyzer boasts an extraordinary testi...

 July 26, 2023 | News

BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears

 To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervi...

 July 24, 2023 | News

Viva Biotech's Portfolio Company, Riparian Pharmaceuticals, Partners with Pfizer for Novel Cardiovascular Programs

In exchange for exclusive rights to a Riparian preclinical program, Pfizer will make upfront and milestone payments, as well as pay royalties on sales of r...

 July 21, 2023 | News

Biotheus Partners with BioNTech in Global Research Collaboration & License Deal

Under the terms of the agreement, Biotheus will grant BioNTech worldwide, exclusive options to a preclinical-stage bispecific antibody and a clinical-stage...

 July 20, 2023 | News

Scribe Therapeutics and Sanofi Team Up to Advance In Vivo Genetic Medicines for Sickle Cell and Genomic Disease

Predicated on the progress of the companies’ first collaboration, Sanofi has selected Scribe’s novel CRISPR by Design™ approach to driv...

 July 18, 2023 | News

Thermo Fisher Scientific Introduces New Reproductive Health Assays to Accelerate Fertility Research

o extend the benefits of genomic testing research for reproductive health labs, Thermo Fisher Scientific today launched two new next-generation sequencing-...

 July 18, 2023 | News

Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination

-  ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...

 July 18, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close